Related Experiment Video
Updated: Jul 9, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Safety and Effectiveness of Probiotics in Preterm Infants with Necrotizing Enterocolitis
Laura N Calvo1, Rachel G Greenberg1,2, Keyaria D Gray1
1Department of Pediatrics, Duke University School of Medicine, Durham, NC.
Insights
Necrotizing enterocolitis (NEC) in preterm infants is linked to gut dysbiosis. This review examines probiotics as a potential intervention to improve gut health and reduce NEC rates in vulnerable newborns.
Area of Science:
- Neonatal Medicine
- Microbiology
- Gastroenterology
Background:
- Necrotizing enterocolitis (NEC) is a significant cause of illness and death in premature infants.
- The exact causes of NEC are not fully understood, but gut dysbiosis (microbial imbalance) is a suspected major factor.
- Altered gut microbiota in preterm infants may predispose them to NEC development.
Conclusions:
- Gut dysbiosis is a critical factor in necrotizing enterocolitis pathogenesis.
- Probiotics represent a promising therapeutic strategy for NEC prevention in preterm infants.
- Continued investigation into probiotic efficacy and safety is warranted for clinical application.
Abstract:
Although necrotizing enterocolitis is a leading cause of morbidity and mortality among preterm infants, its underlying pathophysiology is not fully understood. Gut dysbiosis, an imbalance between commensal and pathogenic microbes, in the preterm infant is likely a major contributor to the development of necrotizing enterocolitis. In this review, we will discuss the increasing use of probiotics in the NICU, an intervention aimed to mitigate alterations in the gut microbiome. We will review the existing evidence regarding the safety and effectiveness of probiotics, and their potential to reduce rates of necrotizing enterocolitis in preterm infants.
Related Concept Videos
Probiotics
Development of Human Microbiota
Microbiota Modulation by Antibiotics

